Sami Ulus Children Hospital, Metabolism Unit, Ankara, Turkey.
Department of Pediatrics, Metabolism Unit, Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Am J Med Genet A. 2020 Jul;182(7):1608-1614. doi: 10.1002/ajmg.a.61590. Epub 2020 Apr 7.
Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (mHS) deficiency is a very rare autosomal recessive inborn error of ketone body synthesis and presents with hypoketotic hypoglycemia, metabolic acidosis, lethargy, encephalopathy, and hepatomegaly with fatty liver precipitated by catabolic stress. We report acute presentation of two patients from unrelated two families with novel homozygous c.862C>T and c.725-2A>C mutations, respectively, in HMGCS2 gene. Affected patients had severe hypoketotic hypoglycemia, lethargy, encephalopathy, severe metabolic and lactic acidosis and hepatomegaly after infections. Surprisingly, molecular screening of the second family showed more affected patients without clinical findings. These cases expand the clinic spectrum of this extremely rare disease.
线粒体 3-羟基-3-甲基戊二酰辅酶 A 合酶(mHS)缺乏症是一种非常罕见的常染色体隐性遗传酮体合成障碍,表现为低酮性低血糖、代谢性酸中毒、嗜睡、脑病和肝肿大伴脂肪变性,由分解代谢应激引起。我们报告了来自两个无关家庭的两名患者的急性表现,他们分别携带 HMGCS2 基因中的新型纯合 c.862C>T 和 c.725-2A>C 突变。受影响的患者在感染后出现严重的低酮性低血糖、嗜睡、脑病、严重的代谢性酸中毒和乳酸酸中毒以及肝肿大。令人惊讶的是,第二家系的分子筛查显示出更多无临床发现的受影响患者。这些病例扩展了这种极其罕见疾病的临床谱。